0001493152-26-023751
SEC filingOperating loss narrowed 24.9% on lower R&D costs, but net loss widened 10.5% as other income fell; cash burn increased amid strategic pivot to laser-based computing.
Operating loss for the first quarter of fiscal 2026 was -$1.9 million, a 24.9% improvement from -$2.5 million in the prior-year period. The decrease is primarily due to the costs associated with corporate branding efforts during the three months ended March 31, 2026, in connection with the Company’s quantum-class laser-based computing business strategy. The increase in personal cost directly relates to the increased compensation (salaries) of the new employees hired in 2026.
Net loss for the quarter was -$1.2 million, compared to -$1.1 million in the prior-year period, a 10.5% increase. The widening net loss reflects a decline in other income, partially offset by the improved operating results. Diluted earnings per share improved to -$0.19 from -$0.36, reflecting the narrower operating loss and a change in share count.
Net cash used in operating activities was -$3.3 million for the quarter, compared to -$2.6 million in the prior-year period. The increase in cash burn is primarily due to higher working capital outflows, including increased receivables and payables related to the strategic pivot.
Management states that existing cash and marketable securities are sufficient to fund operations for at least the next twelve months. However, the company acknowledges that its ability to continue as a going concern depends on increasing revenues, managing expenses, and accessing additional capital. With no product revenue and a history of operating losses, the company will need to raise funds through warrant exercises, equity or debt financings, or asset sales. The strategic pivot to laser-based computing adds execution risk and will likely require further investment before generating revenue.
The company is transitioning from pharmaceutical development to energy-efficient blockchain and cryptocurrency infrastructure using quantum-class laser processing units (qc-LPU100). This shift is supported by an exclusive global licensing agreement with LightSolver Ltd. and the acquisition of LPU. No revenue has been generated from this new focus, and management expects operating expenses to increase as development activities advance. The success of this pivot is critical to the company's long-term viability, but it introduces significant technological, regulatory, and market adoption risks.